BIOMAT Database Logo BIOMAT Database Logo

Synthesis and anti-candida potential of certain novel 1-[(3-Substituted-3-phenyl)propyl]-1H-imidazoles. 2011

Mohamed Nabil Aboul-Enein, and Aida Abd El-Sattar El-Azzouny, and Mohamed Ibrahim Attia, and Ola Ahmed Saleh, and Amany Lotfy Kansoh
Medicinal and Pharmaceutical Chemistry Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, Giza, Egypt. mnaboulenein@yahoo.com

The synthesis and anti-Candida activity of 1-[(3-aroyloxy-3-phenyl)propyl]-1H-imidazoles 5a-f and 1-[(3-alkyl/aralkyl/phenyl-3-phenyl)propan-3-ol]-1H-imidazoles 5g-j are reported. The influence of the ester formation and different substitutions on the anti-Candida activity of the alcohol 4 was investigated. Among the newly developed bioactive chemical entities, compounds 5b and 5c displayed minimum inhibitory concentrations (MICs) against Candida albicans and Candida pseudotropicales comparable to that of tioconazole and more potent than miconazole.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002175 Candida A genus of yeast-like mitosporic Saccharomycetales fungi characterized by producing yeast cells, mycelia, pseudomycelia, and blastophores. It is commonly part of the normal flora of the skin, mouth, intestinal tract, and vagina, but can cause a variety of infections, including CANDIDIASIS; ONYCHOMYCOSIS; VULVOVAGINAL CANDIDIASIS; and CANDIDIASIS, ORAL (THRUSH). Candida guilliermondii var. nitratophila,Candida utilis,Cyberlindnera jadinii,Hansenula jadinii,Lindnera jadinii,Monilia,Pichia jadinii,Saccharomyces jadinii,Torula utilis,Torulopsis utilis,Monilias
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Mohamed Nabil Aboul-Enein, and Aida Abd El-Sattar El-Azzouny, and Mohamed Ibrahim Attia, and Ola Ahmed Saleh, and Amany Lotfy Kansoh
1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies.
July 2008, Journal of medicinal chemistry,
Mohamed Nabil Aboul-Enein, and Aida Abd El-Sattar El-Azzouny, and Mohamed Ibrahim Attia, and Ola Ahmed Saleh, and Amany Lotfy Kansoh
Synthesis and Anti-cancer Activity of 3-substituted Benzoyl-4-substituted Phenyl-1H-pyrrole Derivatives.
January 2017, Anti-cancer agents in medicinal chemistry,
Mohamed Nabil Aboul-Enein, and Aida Abd El-Sattar El-Azzouny, and Mohamed Ibrahim Attia, and Ola Ahmed Saleh, and Amany Lotfy Kansoh
Synthesis and QSAR studies on hypotensive 1-[3-(4-substituted phenylthio) propyl]-4-(substituted phenyl) piperazines.
March 2007, Bioorganic & medicinal chemistry letters,
Mohamed Nabil Aboul-Enein, and Aida Abd El-Sattar El-Azzouny, and Mohamed Ibrahim Attia, and Ola Ahmed Saleh, and Amany Lotfy Kansoh
Synthesis and Spectroscopic Analysis of Novel 1H-Benzo[d]imidazoles Phenyl Sulfonylpiperazines.
May 2012, Pharmaceuticals (Basel, Switzerland),
Mohamed Nabil Aboul-Enein, and Aida Abd El-Sattar El-Azzouny, and Mohamed Ibrahim Attia, and Ola Ahmed Saleh, and Amany Lotfy Kansoh
Synthesis and anti-inflammatory activity of some novel 3-phenyl-N-[3-(4-phenylpiperazin-1yl)propyl]-1H-pyrazole-5-carboxamide derivatives.
July 2011, Bioorganic & medicinal chemistry letters,
Mohamed Nabil Aboul-Enein, and Aida Abd El-Sattar El-Azzouny, and Mohamed Ibrahim Attia, and Ola Ahmed Saleh, and Amany Lotfy Kansoh
Synthesis and Biological Activity of New Series of N-[3-(1H-1,2,3-Benzotriazol-1-yl)propyl]-2-(substituted Phenyl)-3-Chloro-4-Oxo-1-Azetidinecarboxamide.
March 2011, Acta chimica Slovenica,
Mohamed Nabil Aboul-Enein, and Aida Abd El-Sattar El-Azzouny, and Mohamed Ibrahim Attia, and Ola Ahmed Saleh, and Amany Lotfy Kansoh
Synthesis, potential anti-inflammatory and analgesic activities study of (S)-N-substituted-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxamides.
August 2017, Bioorganic & medicinal chemistry letters,
Mohamed Nabil Aboul-Enein, and Aida Abd El-Sattar El-Azzouny, and Mohamed Ibrahim Attia, and Ola Ahmed Saleh, and Amany Lotfy Kansoh
Synthesis and QSAR evaluation of 2-(substituted phenyl)-1H-benzimidazoles and [2-(substituted phenyl)-benzimidazol-1-yl]-pyridin-3-yl-methanones.
March 2009, European journal of medicinal chemistry,
Mohamed Nabil Aboul-Enein, and Aida Abd El-Sattar El-Azzouny, and Mohamed Ibrahim Attia, and Ola Ahmed Saleh, and Amany Lotfy Kansoh
Design, synthesis and biological evaluation of 3-substituted 2,5-dimethyl-N-(3-(1H-tetrazol-5-yl)phenyl)pyrroles as novel potential HIV-1 gp41 inhibitors.
November 2011, Bioorganic & medicinal chemistry,
Mohamed Nabil Aboul-Enein, and Aida Abd El-Sattar El-Azzouny, and Mohamed Ibrahim Attia, and Ola Ahmed Saleh, and Amany Lotfy Kansoh
Antimycotic imidazoles. 3. Synthesis and antimycotic properties of 1-[2-(aryloxyalkyl)-2-phenylethyl]-1H-imidazoles.
November 1977, Journal of medicinal chemistry,
Copied contents to your clipboard!